Line of work

SARS-CoV-2 Outcomes in Immunocompromised and Cancer Populations

This research analyzes the susceptibility, severity, and vaccination response of patients with cancer and other immune-mediated conditions during the COVID-19 pandemic. It utilizes large-scale cohort data to refine severity metrics and identify high-risk subgroups.

Anchor result

COVID-19 vaccination showed a 58% overall effectiveness in cancer patients, though effectiveness was notably lower in those receiving chemotherapy.

Related publications

2025
2023
2023
2022
2022
2020